Synthesis of 1-phenyl-2-styryl-3,5-dioxopyrazolidines as antiinflammatory agents.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D011720:Pyrazoles / Q000138:chemical synthesis* / Q000627:therapeutic use; D051381:Rats; D013343:Styrenes / Q000138:chemical synthesis* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D013343:Styrenes; D002351:Carrageenan; D010653:Phenylbutazone; D010113:Oxyphenbutazone